The amyloid 13 protein induces oxidative damage of mitochondrial DNA

Journal of Neuropathology and Experimental Neurology

Volumn 56, Issue 12, 1997, Pages 1356-1362

  Bozner, Peter ^a   Grishko, Valentina ^b   LeDoux, Susan P ^b   Wilson, Glenn L ^b   Chyan, Y C ^c   Pappolla, Miguel A ^a  

^a UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH ALABAMA   (United States)

^c NONE

Author keywords

Alzheimer disease; Amyloid; Beta peptide; DNA; Melatonin; Mitochondria; Oxidative stress

Indexed keywords

AMYLOID BETA PROTEIN; ENDONUCLEASE; GLYCOSYLTRANSFERASE; MELATONIN; MITOCHONDRIAL DNA; DIETHYLDITHIOCARBAMIC ACID;

ALZHEIMER DISEASE; ANIMAL CELL; ANTIOXIDANT ACTIVITY; BRAIN MITOCHONDRION; CELL PROTECTION; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; DNA PROBE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; REVIEW; SOUTHERN BLOTTING; ANIMAL; ARTICLE; CELL STRAIN; DRUG EFFECT; PHYSIOLOGY;

AMYLOID BETA-PROTEIN; ANIMALS; BLOTTING, SOUTHERN; DITIOCARB; DNA DAMAGE; DNA, MITOCHONDRIAL; MELATONIN; OXIDATIVE STRESS; PC12 CELLS; RATS;

EID: 0031283127     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199712000-00010     Document Type: Review

References (66)

1. Glenner GG, Wong CW. Alzheimers disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 1984;120:885-90
2. 42 deposition in a transgenic mouse model of Alzheimer disease. Proc Natl Acad Sci USA 1997;94:1550-55
3. Hsiao K, Chapman P, Nilsen S, et al. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science 1996;274:99-102
4. Games D, Adams D, Alessandrini R, et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 1995;373:523-27
5. Behl C, Davis JB, Lesley R, Schubert D. Hydrogen peroxide mediates amyloid β protein toxicity. Cell 1994;77:817-27
6. Pappolla MA, Sos M, Omar RA, et al. Melatonin prevents death of neuroblastoma cells exposed to the Alzheimer amyloid peptide. J Neurosci 1997;17:1683-90
7. Harris ME, Hensley K, Butterfield DA, Leedle RA, Carney JM. Direct evidence of oxidative injury produced by the Alzheimer's β-amyloid peptide (1-40) in cultured hippocampal neurons. Exp Neurol 1995;131:193-202
8. Pappolla MA, Omar RA, Kim KS, Robakis NK. Immunohistochemical evidence of oxidative stress in Alzheimer's disease. Am J Pathol 1992;140:621-28
9. Smith MA, Perry G, Richey PL, et al. Oxidative damage in Alzheimer's. Nature 1996;382:120-21
10. Good PF, Werner P, Hsu A, Olanow CW, Perl DP. Evidence for neuronal oxidative damage in Alzheimer's disease. Am J Pathol 1996;149:21-28
11. Sayre LM, Zelasko DA, Harris PLR, et al. 4-hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J Neurochem 1997;68:2092-97
12. Smith MA, Harris PLR, Sayre LM, Beckman JS, Perry G. Widespread peroxynitrite-mediated damage in Alzheimer's disease. J Neurosci 1997;17:2653-57
13. Subbarao KV, Richardson JS, Ang LC. Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro. J Neurochem 1990;55:342-45
14. Smith CD, Carney JM, Starke-Reed PE, et al. Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc Natl Acad Sci USA 1991;88:10540-43
15. Troncoso JC, Costello A, Watson AL Jr, Johnson GVW. In vitro polymerization of oxidized tau into filaments. Brain Res 1993;613: 313-16
16. Schweers O, Mandelkow EM, Biernat J, Mandelkow E. Oxidation of cysteine-322 in the repeat domain of microtubule-associated protein tau controls the in vitro assembly of paired helical filaments. Proc Natl Acad Sci USA 1995; 92: 8463-67
17. Smith MA, Rudnicka-Nawrot M, Richey PL, et al. Carbonyl-related posttranslational modification of neurofilament protein in the neurofibrillary pathology of Alzheimer's disease. J Neurochem 1995; 64:2660-66
18. Busciglio J, Lorenzo A, Yen J, Yankner BA. β-amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron 1995;14:879-88
19. Grundke-Iqbal I, Iqbal K, Tung Y-C, Quinlan M, Wisniewski HM, Binder LI. Abnormal phosphorylation of the microtubule-associated protein tau in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA 1986;83:4913-17
20. Kosik KS, Joachim CL, Selkoe DJ. Microtubule-associated protein tau is a major antigenic component of paired helical filaments in Alzheimer disease. Proc Natl Acad Sci USA 1986;83:4044-48
21. Wood JG, Mirra SS, Pollock NJ, Binder LI. Neurofibrillary tangles of Alzheimer disease share antigenic determinants with the axonal microtubule-associated protein tau. Proc Natl Acad Sci USA 1986; 83:4040-43
22. Hensley K, Carney JM, Mattson MP, et al. A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: Relevance to Alzheimer disease. Proc Natl Acad Sci USA 1994;91:3270-74
23. Gutteridge JM. Free radicals in disease processes: A compilation of cause and consequence. Free Radical Res Commun 1993;19: 141-58
24. Mecocci P, MacGarvey U, Beal MF. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann Neurol 1994;36:747-51
25. Yankner BA, Duffy LK, Kirschner DA. Neurotrophic and neurotoxic effects of amyloid β protein: Reversal by tachykinin neuropeptides. Science 1990; 250:279-82
26. Demple B, Levin JD. Oxidants and antioxidants. In: Sies H, ed. Oxidative stress. London: Academic Press Ltd.; 1991:127-42
27. Tchou J, Kasai H, Shibutani S, et al. 8-oxoguanine (8-hydroxyguanine) DNA glycosylase and its substrate specificity. Proc Natl Acad Sci USA 1991;88:4690-94
28. Pettepher CC, Ledoux SP, Bohr VA, Wilson GL. Repair of alkali-labile sites within the mitochondrial DNA of RINr 38 cells after exposure to the nitrosourea streptozotocin. J Biol Chem 1991;266: 3113-17
29. Driggers WJ, Ledoux SP, Wilson GL. Repair of oxidative damage within the mitochondrial DNA of RINr 38 cells. J Biol Chem 1993; 29:22042-45
30. Driggers WJ, Grishko VI, LeDoux SP, Wilson GL. Defective repair of oxidative damage in the mitochondrial DNA of a xeroderma pigmentosum group A cell line. Cancer Res 1996;56:1262-66
31. Rothstein JD, Bristol LA, Hosler B, Brown RH, Kuncl RW. Chronic inhibition of Superoxide dismutase produces apoptotic death of spinal neurons. Proc Natl Acad Sci USA 1994;91:4155-59
32. Omar RA, Pappolla MA. Superoxide anion induces heat shock protein synthesis in cultured neuroblastoma cells. Eur Arch Psych Clin Neurose 1993;242:262-67
33. Dizdaroglu M, Rao G, Halliwell B, Gajewski E. Damage to the DNA bases in mammalian chromatin by hydrogen peroxide in the presence of ferric and cupric ions. Arch Biochem Biophys 1991; 285:317-24
34. Yakes FM, VanHouten B. Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc Natl Acad Sci USA 1997;94: 514-19
35. Chen Q, Ames BN. Senescence-like growth arrest induced by hydrogen peroxide in human diploid fibroblast F65 cells. Proc Natl Acad Sci USA 1994;91:4130-34
36. Prehn JHM, Bindokas VP, Jordan J, et al. Protective effect of transforming growth factor-β1 on β-amyloid neurotoxicity in rat hippocampal neurons. Molec Pharmacol 1996;49:319-28
37. Shearman MS, Ragan CI, Iversen LL. Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of β-amyloid-mediated cell death. Proc Natl Acad Sci USA 1994;91: 1470-74
38. Imlay JA, Chin SM, Linn S. Toxic DNA damage by hydrogen peroxide through the Fenton reaction in vivo and in vitro. Science 1988;240:1302-9
39. Halliwell B, Gutheridge JMC. Free radicals in Biology and Medicine. Oxford: Oxford University Press, 1989
40. Van SD, Chen X, Fu J, et al. RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature 1996;382:685-91
41. Mattson MP, Cheng B, Davis D, Bryant K, Lieberburg I, Rydel RE. β-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci 1992; 12:376-89
42. Morel F, Doussiere J, Vignais PV. The superoxide-generating oxidase of phagocytic cells. Eur J Biochem 1991;201:523-46
43. Beal MF. Mitochondria, free radicals, and neurodegeneration. Curr Opin Neurobiol 1996;6:661-66
44. Tan DX, Chen LD, Poeggeler B, Manchester LC, Reiter RJ. Melatonin: A potent, endogenous hydroxyl radical scavenger. Endocrine J 1993a;1:57-60
45. Pieri C, Morra M, Maroni F, Recchioni R, Marcheselli F. Melatonin: A peroxyl radical scavenger more effective than vitamin E. Life Sci 1994;55:PL271-P1276
46. Reiter RJ, Melchiori D, Sewerynek B, et al. A review of the evidence supporting melatonin's role as an antioxidant. J Pineal Res 1995;18:1-11
47. Pierpaoli W, Dall'Ara A, Pedrinis E, Regelson W. The pineal control of aging. The effects of melatonin and pineal grafting on the survival of older mice. Ann N Y Acad Sci 1991;621:291-313
48. Tan DX, Poeggeler B, Reiter RJ, et al. The pineal hormone melatonin inhibits DNA-adduct formation induced by the chemical carcinogen safrole in vivo. Cancer Lett 1993b;70:65-71
49. Tan DX, Reiter RJ, Chen LD, Poeggeler B, Manchester LC, Barlow-Walden LR. Both physiological and pharmacological levels of melatonin reduce DNA adduct formation induced by the carcinogen safrole. Carcinogenesis 1994;15:215-18
50. Cagnoli CM, Atabay C, Kharlamova E, Manev H. Melatonin protects neurons from singlet oxygen-induced apoptosis. J Pineal Res 1995;18:222-26
51. Uz T, Giusti P, Franceschini D, Kharlamova A, Manev H. Protective effect of melatonin against hippocampal DNA damage induced by intraperitoneal administration of kainate to rats. Neuroscience 1996; 73:631-36
52. Manev H, Uz T, Kharlamov A, Cagnoli CM, Franceschini D, Giusti P. In vivo protection against kainate-induced apoptosis by the pineal hormone melatonin: Effect of exogenous melatonin and circadian rhythm. Restor Neurol Neurosci 1996;9:251-56
53. Blinkinstaff RT, Brandstadter SM, Reddy S, Witt R. Potential radioprotective agents. 1. Homologs of melatonin. J Pharm Sci 1994; 83:216-18
54. Vijayalaxmi, Reiter RJ, Meltz ML. Melatonin protects human blood lymphocytes from radiation-induced chromosome damage. Mutat Res 1995;346:23-31
55. Dubocovich ML. Melatonin receptors: Are there multiple subtypes? Trends Pharmacol Sci 1995;16:50-56
56. Becker-Andre M, Wiesenberg I, Schaeren-Wiemers N, et al. Pineal gland hormone melatonin binds and activates an orphan of the nuclear receptor superfamily. J Biol Chem 1994;269:28531-34
57. Popova JS, Dubocovich ML. Melatonin receptor-mediated stimulation of phosphoinositide breakdown in chick brain slices. J Neurochem 1995;64:130-38
58. Franchi AM, Gimeno MF, Cardinali DP, Vacas MI. Melatonin, 5-methoxytryptamine and some of their analogs as cyclooxygenase inhibitors in rat medial basal hypothalamus. Brain Res 1987;405: 384-88
59. Benitez-King G, Anton-Tay F. Calmodulin mediates melatonin cytoskeletal effects. Experientia 1993;49:635-41
60. Huerto-Delgadillo L, Anto-Tay F, Benitez-King G. Effects of melatonin on microtubule assembly depend on hormone concentration: Role of melatonin as a calmodulin antagonist. J Pineal Res 1994; 17:55-62
61. Iguchi H, Kato K, Ibayashi H. Age-dependent reduction in serum melatonin concentrations in healthy subjects. J Clin Endocrinol Metabol 1982;55:27-29
62. Dori D, Casale G, Solerte SB, et al. Chrono-neuroendocrinological aspects of physiological aging and senile dementia. Chronobiol 1994;21:121-26
63. Sack RL, Lewy AJ, Erb DL, Vollmer WM, Singer CM. Human melatonin production decreases with age. J Pineal Res 1986;3:379-88
64. Skene DJ, Vivien-Roels B, Sparks DL, et al. Daily variation in the concentration of melatonin and 5-methoxytryptophol in the human pineal gland: Effect of age and Alzheimer's disease. Brain Res 1990;528:170-74
65. Souetre E, Salvati E, Krebs B, Belugou JL, Darcourt G. Abnormal melatonin response to 5-methoxypsoralen in dementia. Am J Psychiatry 1989;146:1037-40
66. Mishima K, Okawa M, Hishikawa Y, Hozumi S, Hori H, Takahashi K. Morning bright light therapy for sleep and behavior disorders in elderly patients with dementia. Acta Psychiatr Scand 1994;89:1-7